Breast cancer is the most common cancer among women worldwide.1 Oestrogen receptor (ER) and progesterone receptor (PR), which are members of the nuclear receptor superfamily of transcription factors, are important in predicting prognosis and establishing therapeutic strategies for breast cancer treatment. This evidence concerns the gene PGR and cancer.